Lupin has received approval for its Albendazole Tablets USP, 200 mg, from the United States Food and Drug Administration (USFDA), to market a generic equivalent of Albenza Tablets, 200 mg, of Impax Laboratories Inc.
Albendazole Tablets USP, 200 mg, are an anthelmintic drug indicated for treatment of Parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm and for Cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm. Albendazole Tablets USP (RLD: Albenza) had an annual sales of approximately $34 million in the U.S. (IQVIA MAT April 2020).
Lupin is an innovationled transnational pharmaceutical company headquartered in Mumbai, India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: